However, intestine-specific FXR-deficiency (intFXR KO) and pharmacological inhibition of intestinal FXR protect mice from high fat diet (HFD)-induced obesity, insulin resistance and non-alcoholic fatty liver diseases (NAFLD)21–24. This evidence concerns the gene NR1H4 and Insulin resistance.